Pan-emerging markets private equity fund manager Capital Group Private Markets has acquired a 3 percent stake in India-based Intas Pharmaceuticals from India-focused private equity firm ChrysCapital for a reported US$107 million. ChrysCapital, which will retain a 3 percent stake in the company, originally invested in Intas in 2006 through ChrysCapital III and subsequently in 2012 through ChrysCapital IV.